Skip to main content
Fig. 4 | Clinical Proteomics

Fig. 4

From: Erratum to: Characterization of Nitrotyrosine-Modified Proteins in Cerebrospinal Fluid

Fig. 4

1-D electrophoresis (a) of nitrotyrosine enrichment fractions from pooled non-HIV (control) and HAND CSF. Lane 1, MW marker; lane 2, flowthrough (non-nitrated proteins); lane 3, pre-elution PBS wash; and lane 4, 5% formic acid elution (enriched nitrated proteins). The total number of spectra acquired (normalized spectrum count) from Non-HIV (control) and HAND CSF nitrotyrosine-modified subproteome (a). Quantitative immunoblot analysis of nitrotyrosine content in albumin/IgG-depleted non-HIV (control) and HAND (diseased) CSF (b) and L-PGDS (c) determined by slot blot analysis

Back to article page